In gastric cancer cells, H19 inhibits glucose consumption primarily via the H19/miR-519d-3p/LDHA axis, promotes aerobic glycolysis, proliferation, and regulates immune cell activity, including T cells, Jurkat cells, and TAMs (Sun et al., 2021). This evidence concerns the gene H19 and gastric cancer.